CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-09 | Francois Eric Chief Financial Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2018-02-09 | Taglietti Marco Chief Executive Officer | Grant or award · Stock option (right to buy) | +375,000 | 375,000 | ||
| 2018-02-09 | Sukenick Scott General Counsel | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2018-01-02 | McCourt Marion Director | Grant or award · Stock Option (right to buy) | +6,831 | $1.48 | $10K | 6,831 |
| 2018-01-02 | McCourt Marion Director | Grant or award · Stock Option (right to buy) | +19,989 | 19,989 | ||
| 2018-01-02 | Machado Patrick Director | Grant or award · Stock Option (right to buy) | +19,989 | 19,989 | ||
| 2018-01-02 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +11,555 | $1.48 | $17K | 11,555 |
| 2018-01-02 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +19,989 | 19,989 | ||
| 2018-01-02 | HASTINGS DAVID C Director | Grant or award · Stock Option (right to buy) | +19,989 | 19,989 | ||
| 2018-01-02 | HANHAM ANN Director | Grant or award · Stock Option (right to buy) | +19,989 | 19,989 | ||
| 2018-01-02 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +19,989 | 19,989 | ||
| 2017-11-15 | Sukenick Scott General Counsel | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2017-10-02 | McCourt Marion Director | Grant or award · Stock Option (right to buy) | +6,332 | 6,332 | ||
| 2017-10-02 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +10,709 | 10,709 | ||
| 2017-10-02 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +1,807 | 1,807 | ||
| 2017-09-22 | Taglietti Marco Chief Executive Officer | Purchase | +10,000 | $2.23 | $22K | 303,000 |
| 2017-08-23 | Taglietti Marco Chief Executive Officer | Purchase | +4,993 | $1.85 | $9K | 292,000 |
| 2017-08-22 | Taglietti Marco Chief Executive Officer | Purchase | +7 | $1.61 | $11 | 287,007 |
| 2017-08-15 | Taglietti Marco Chief Executive Officer | Purchase | +10,000 | $1.61 | $16K | 287,000 |
| 2017-08-11 | Angulo Gonzalez David Chief Medical Officer | Purchase | +10,000 | $1.55 | $16K | 72,000 |
Page 12 of 15 · 286 trades